| Trial Acronym | AnakARDS |
| Trial Title | A phase 2 randomised clinical trial to evaluate the efficacy of anakinra in patients with the acute respiratory distress syndrome |
| Clinical Area | Critical Care |
| Trial Status | Set Up |
| Trial Registration |
-
Recruitment
Recruitment Target 132 Date Open to Recruitment Recruitment Date Closed to Recruitment -
Trial Design
Trial Design A phase 2, multi-centre, randomised, allocation concealed, controlled, open label clinical trial in patients with ARDS Study Aim To evaluate the efficacy of anakinra as a novel therapeutic for patients with ARDS within a phase 2 clinical trial -
Chief Investigator (CI)
Chief Investigator Dr Andrew Boyle, Queen’s University Belfast Email andrew.boyle@qub.ac.uk -
Sponsor(s) & Funder(s)
Sponsor Belfast Health and Social Care Trust Funder Medical Research Council (MRC)-National Institute for Health and Care Research (NIHR) Efficacy and Mechanism Evaluation (EME) Programme; NIHR168885